Is This Space Exploration Company Your Best Bet for 2019?

Maxar Technologies (TSX:MAXR)(NYSE:MAXR) is dealing with a huge setback, but things could turn uglier quickly this year.

| More on:

One of Warren Buffett’s most famous bits of wisdom is to be fearful when others are greedy, and greedy when others are fearful. There’s a lot of fear surrounding Maxar Technologies (TSX:MAXR)(NYSE:MAXR) right now. Is it time to get greedy?

Maxar operates on the bleeding edge of space technology

After hitting an all-time high of $100 in 2015, Maxar stock is down to just $10 at writing. The market it operates in remains strong, and most of its problems are of its own making.

Maxar describes itself as providing advanced space technology solutions, end-to-end capabilities in satellites, robotics, earth imagery, geospatial data, and analytics. The company consists of four different businesses all housed under the same corporation given the benefits of providing an integrated offering to customers. If a customer needs one service, it’s very likely to need one of the other three. Cross-selling and shared expertise are huge benefits of Maxar’s corporate structure.

In total, the company has a 60-year track record of space expertise. It’s building the satellite communications subsystem for the European Space Agency. It’s supplying sensors for a client specializing in last mile logistics in space. The company even made the robotic arms for NASA’s InSight Lander that recently touched ground on Mars.

A torrent of bad news

At its height, Maxar had a $6 billion market cap. Today, it’s down to around $600 million. For such a successful company operating in a high growth industry with barriers to entry, what’s caused such a severe collapse?

In July, Maxar’s management suggested that investors should prepare for a full year of revenue declines. They expected sales to fall between 2% and 4% on an annual basis. The stock dropped given the market anticipated high growth rates for years to come. Still, EBITDA margins were expected to be a healthy 33%, generating cash flow from operations of around $350 million—about half of the current market cap.

In August, Spruce Point Capital Management released a short-seller report noting that shares could fall 50% or more. Their price target was around $20 per share, but noted that long term, there could be 100% downside, meaning shareholders would leave with nothing.

The report’s biggest claim is that Maxar’s management team has engaged in a latticework of accounting schemes and shenanigans, and the facts seem to support their claims. For example, Maxar’s CEO Howard Lance was involved in two other accounting scandals earlier in his career, both of which required complete reviews and restatements of the related financial statements. In summary, the report believes Maxar’s claims of huge margins and cash flows are a lie, or at least misleading.

For example, Maxar chose to extend the depreciable lives of its asset base twice in 2018. Management also chose to accelerate the recognition of tax credits while booking one-time gains from its retirements plan. Each of these on their own would be considered aggressive accounting practices.

Leave this stock in outer space

In a classic response, Maxar’s management team released a statement claiming that the short-seller report “contains a number of inaccurate claims and misleading statements.” The company believes the report was “a direct attempt by a short-seller to profit.” This type of reaction is the cliche, canned response you can expect from any company. Notably, Maxar refused to respond in detail to the report’s claims, possibly because their defense would be lackluster.

In time, the truth will come out, but it’s best to stay on the sidelines for now. The market is fearful, but you should be too. Perhaps another Warren Buffet quote is more apt: “Charlie and I look for companies that have…able and trustworthy management.” Unfortunately, we can’t say the same for Maxar.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Ryan Vanzo has no position in any stocks mentioned. Maxar is a recommendation of Stock Advisor Canada.

More on Tech Stocks

Canada Day fireworks over two Adirondack chairs on the wooden dock in Ontario, Canada
Tech Stocks

Best Tech Stocks for Canadian Investors in the New Year

Three tech stocks are the best options for Canadians investing in the high-growth sector.

Read more »

doctor uses telehealth
Tech Stocks

What to Know About Canadian Small-Cap Stocks for 2025

Small cap stocks are a great way to experience outsized gains. Here is what you need to know about small…

Read more »

A worker drinks out of a mug in an office.
Tech Stocks

A Top-Performing U.S. Stock That Canadian Investors Really Should Own

Canadian investors should buy and hold this top performing U.S. stock for generating significant returns in the long run.

Read more »

dividends grow over time
Tech Stocks

Got $1,500? 2 Tech Stocks to Buy and Hold Forever

Two tech stocks with high-growth potential are sound prospects for long-term investors.

Read more »

Soundhound AI is a leader in voice recognition software
Tech Stocks

3 Tech Stocks I’m Looking to Buy in January

From tech stocks with consistent growth histories to stocks experiencing a temporary bullish momentum, there are multiple attractive options in…

Read more »

The TFSA is a powerful savings vehicle for Canadians who are saving for retirement.
Tech Stocks

Take Full Advantage of Your TFSA: Growth Strategies for 2025

Maximize your TFSA in 2025 with proven growth strategies. Learn how to build a tax-free portfolio, avoid common mistakes, and…

Read more »

up arrow on wooden blocks
Tech Stocks

1 Soaring Stock I’d Buy Now With No Hesitation

Although it's from a rapidly evolving discipline and carries unique risks, the robotics stock's growth potential is too formidable and…

Read more »

Biotech stocks
Tech Stocks

Digital Healthcare Boom: 2 TSX Stocks Transforming Canadian Medicine

Even though telehealth stocks carry the risk factor of the tech sector and other innovative stocks, the profit margin can…

Read more »